Morgan Stanley’s Burning Rock Biotech BNR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $57.5K | Buy |
18,207
+7,481
| +70% | +$23.6K | ﹤0.01% | 6311 |
|
2025
Q1 | $48.3K | Hold |
10,726
| – | – | ﹤0.01% | 6276 |
|
2024
Q4 | $72.4K | Buy |
10,726
+300
| +3% | +$2.03K | ﹤0.01% | 6176 |
|
2024
Q3 | $34K | Sell |
10,426
-5,557
| -35% | -$18.1K | ﹤0.01% | 6330 |
|
2024
Q2 | $103K | Sell |
15,983
-6,405
| -29% | -$41.3K | ﹤0.01% | 5953 |
|
2024
Q1 | $163K | Sell |
22,388
-41,574
| -65% | -$303K | ﹤0.01% | 5792 |
|
2023
Q4 | $595K | Buy |
63,962
+31,974
| +100% | +$297K | ﹤0.01% | 5550 |
|
2023
Q3 | $310K | Sell |
31,988
-31,385
| -50% | -$304K | ﹤0.01% | 5381 |
|
2023
Q2 | $1.36M | Sell |
63,373
-13,992
| -18% | -$301K | ﹤0.01% | 4646 |
|
2023
Q1 | $2.17M | Sell |
77,365
-13,836
| -15% | -$389K | ﹤0.01% | 4415 |
|
2022
Q4 | $2.05M | Sell |
91,201
-298
| -0.3% | -$6.71K | ﹤0.01% | 4445 |
|
2022
Q3 | $2.19M | Sell |
91,499
-5,921
| -6% | -$142K | ﹤0.01% | 4365 |
|
2022
Q2 | $2.83M | Buy |
97,420
+8,839
| +10% | +$257K | ﹤0.01% | 4261 |
|
2022
Q1 | $8.23M | Buy |
88,581
+36,109
| +69% | +$3.35M | ﹤0.01% | 3136 |
|
2021
Q4 | $5M | Buy |
52,472
+5,708
| +12% | +$544K | ﹤0.01% | 3718 |
|
2021
Q3 | $8.36M | Buy |
46,764
+31,065
| +198% | +$5.55M | ﹤0.01% | 3103 |
|
2021
Q2 | $4.63M | Buy |
15,699
+15,579
| +12,983% | +$4.59M | ﹤0.01% | 3863 |
|
2021
Q1 | $32K | Sell |
120
-634
| -84% | -$169K | ﹤0.01% | 6553 |
|
2020
Q4 | $174K | Buy |
754
+393
| +109% | +$90.7K | ﹤0.01% | 5660 |
|
2020
Q3 | $90K | Buy |
361
+280
| +346% | +$69.8K | ﹤0.01% | 5472 |
|
2020
Q2 | $22K | Buy |
+81
| New | +$22K | ﹤0.01% | 5979 |
|